AnGes Inc

Research AnGes Inc (AJW) on Bullrun: market cap EUR 97.03M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAJW
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 97.03M
• Financial periodFY2025
• RevenueEUR 874.12M
• Revenue growth35.8%
• Net income-EUR 5.12B
• Free cash flow-EUR 5.76B
• Gross margin36.7%

Valuation Snapshot

latest market cap is EUR 97.03M.

About AnGes Inc

AnGes, Inc. engages in the research and development of gene-based medicines. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-KB decoy oligonucleotide for chronic discogenic lumbar back pain; and DNA vaccines for the treatment of hypertension, as well as tie2 agonists for COVID-19/ARDS and drugs for chronic hepatitis B. AnGes, Inc. was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017.

Frequently asked questions

What is AnGes Inc's market cap?

AnGes Inc's market capitalization is EUR 97.03M.

What does AnGes Inc do?

AnGes, Inc. engages in the research and development of gene-based medicines. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-KB decoy oligonucleotide for chronic discogenic lumbar back pain;